DOCSLIB.ORG

Guidelines on Paediatric Urology S

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Guidelines on Paediatric Urology S Guidelines on Paediatric Urology S. Tekgül (Chair), H.S. Dogan, E. Erdem (Guidelines Associate), P. Hoebeke, R. Ko˘cvara, J.M. Nijman (Vice-chair), C. Radmayr, M.S. Silay (Guidelines Associate), R. Stein, S. Undre (Guidelines Associate) European Society for Paediatric Urology © European Association of Urology 2015 TABLE OF CONTENTS PAGE 1. INTRODUCTION 7 1.1 Aim 7 1.2 Publication history 7 2. METHODS 8 3. THE GUIDELINE 8 3A PHIMOSIS 8 3A.1 Epidemiology, aetiology and pathophysiology 8 3A.2 Classification systems 8 3A.3 Diagnostic evaluation 8 3A.4 Disease management 8 3A.5 Follow-up 9 3A.6 Conclusions and recommendations on phimosis 9 3B CRYPTORCHIDISM 9 3B.1 Epidemiology, aetiology and pathophysiology 9 3B.2 Classification systems 9 3B.3 Diagnostic evaluation 10 3B.4 Disease management 10 3B.4.1 Medical therapy 10 3B.4.2 Surgery 10 3B.5 Follow-up 11 3B.6 Recommendations for cryptorchidism 11 3C HYDROCELE 12 3C.1 Epidemiology, aetiology and pathophysiology 12 3C.2 Diagnostic evaluation 12 3C.3 Disease management 12 3C.4 Recommendations for the management of hydrocele 12 3D ACUTE SCROTUM IN CHILDREN 13 3D.1 Epidemiology, aetiology and pathophysiology 13 3D.2 Diagnostic evaluation 13 3D.3 Disease management 14 3D.3.1 Epididymitis 14 3D.3.2 Testicular torsion 14 3D.3.3 Surgical treatment 14 3D.4 Follow-up 14 3D.4.1 Fertility 14 3D.4.2 Subfertility 14 3D.4.3 Androgen levels 15 3D.4.4 Testicular cancer 15 3D.5 Recommendations for the treatment of acute scrotum in children 15 3E HYPOSPADIAS 15 3E.1 Epidemiology, aetiology and pathophysiology 15 3E.1.1 Risk factors 15 3E.2 Classification systems 15 3E.3 Diagnostic evaluation 16 3E.4 Disease management 16 3E.4.1 Age at surgery 16 3E.4.2 Penile curvature 17 3E.4.3 Preservation of the well-vascularised urethral plate 17 3E.4.4 Re-do hypospadias repairs 17 3E.4.5 Urethral reconstruction 18 3E.4.6 Urine drainage and wound dressing 18 3E.4.7 Outcome 18 3E.5 Follow-up 19 3E.6 Conclusions and recommendations for the management of hypospadias 19 3F CONGENITAL PENILE CURVATURE 19 3F.1 Epidemiology, aetiology and pathophysiology 19 2 PAEDIATRIC UROLOGY - LIMITED UPDATE MARCH 2015 3F.2 Diagnostic evaluation 19 3F.3 Disease management 20 3G VARICOCELE IN CHILDREN AND ADOLESCENTS 20 3G.1 Epidemiology, aetiology and pathophysiology 20 3G.2 Classification systems 20 3G.3 Diagnostic evaluation 20 3G.4 Disease management 21 3G.5 Conclusions and recommendations 21 3H URINARY TRACT INFECTIONS IN CHILDREN 22 3H.1 Epidemiology, aetiology and pathophysiology 22 3H.2 Classification systems 22 3H.2.1 Classification according to site 22 3H.2.2 Classification according to episode 22 3H.2.3 Classification according to severity 23 3H.2.4 Classification according to symptoms 23 3H.2.5 Classification according to complicating factors 23 3H.3 Diagnostic evaluation 23 3H.3.1 Medical history 23 3H.3.2 Clinical signs and symptoms 23 3H.3.3 Physical examination 23 3H.3.4 Urine sampling, analysis and culture 23 3H.3.4.1 Urine sampling 23 3H.3.4.2 Urinalysis 24 3H.3.4.3 Urine culture 25 3H.3.5 Imaging 25 3H.3.5.1 Ultrasound 25 3H.3.5.2 Radionuclide scanning 25 3H.3.5.3 Voiding cystourethrography 25 3H.3.6 Bladder and bowel dysfunction 26 3H.4 Disease management 26 3H.4.1 Administration route 26 3H.4.2 Duration of therapy 26 3H.4.3 Antimicrobial agents 27 3H.4.4 Chemoprophylaxis 29 3H.4.5 Monitoring of UTI 30 3H.5 Conclusions and recommendations for UTI in children 30 3I DAYTIME LOWER URINARY TRACT CONDITIONS 31 3I.1 Epidemiology, aetiology and pathophysiology 31 3I.2 Classification systems 32 3I.2.1 Filling-phase dysfunctions 32 3I.2.2 Voiding-phase (emptying) dysfunctions 32 3I.3 Diagnostic evaluation 32 3I.4 Disease management 32 3I.4.1 Standard therapy 32 3I.4.2 Specific interventions 33 3I.5 Recommendations for the treatment of daytime lower urinary tract conditions 33 3J MONOSYMPTOMATIC ENURESIS 33 3J.1 Epidemiology, aetiology and pathophysiology 33 3J.2 Classification systems 34 3J.3 Diagnostic evaluation 34 3J.4 Disease management 34 3J.4.1 Supportive treatment measures 34 3J.4.2 Alarm treatment 34 3J.4.3 Medication 34 3K MANAGEMENT OF NEUROGENIC BLADDER IN CHILDREN 36 3K.1 Epidemiology, aetiology and pathophysiology 36 3K.2 Classification systems 36 3K.3 Diagnostic evaluation 37 3K.3.1 Urodynamic studies 37 3K.3.1.1 Method of urodynamic study 37 PAEDIATRIC UROLOGY - LIMITED UPDATE MARCH 2015 3 3K.3.1.2 Uroflowmetry 37 3K.3.2 Cystometry 37 3K.4 Disease management 38 3K.4.1 Investigations 38 3K.4.2 Early management with intermittent catheterisation 39 3K.4.3 Medical therapy 39 3K.4.4 Management of bowel incontinence 39 3K.4.5 Urinary tract infection 40 3K.4.6 Sexuality 40 3K.4.7 Bladder augmentation 40 3K.4.8 Bladder outlet procedures 40 3K.4.9 Continent stoma 41 3K.4.10 Total bladder replacement 41 3K.5 Follow-up 41 3L DILATATION OF THE UPPER URINARY TRACT (UPJ and UVJ Obstruction) 41 3L.1 Epidemiology, aetiology and pathophysiology 41 3L.2 Diagnostic evaluation 42 3L.2.1 Antenatal ultrasound 42 3L.2.2 Postnatal ultrasound 42 3L.2.3 Voiding cystourethrogram 42 3L.2.4 Diuretic renography 42 3L.3 Disease management 43 3L.3.1 Prenatal management 43 3L.3.2 UPJ obstruction 43 3L.3.3 Megaureter 43 3L.3.3.1 Nonoperative management 43 3L.3.3.2 Surgical management 43 3L.4 Conclusion 43 3L.4.1 Conclusions and recommendations for UPJ-, UVJ-obstruction 43 3M VESICOURETERIC REFLUX IN CHILDREN 44 3M.1 Epidemiology, aetiology and pathophysiology 44 3M.2 Diagnostic evaluation 45 3M.2.1 Infants presenting because of prenatally diagnosed hydronephrosis 46 3M.2.2 Siblings and offspring of reflux patients 46 3M.2.3 Recommendations for paediatric screening of VUR 46 3M.2.4 Children with febrile urinary tract infections 46 3M.2.5 Children with lower urinary tract symptoms and vesicoureteric reflux 47 3M.3 Disease management 47 3M.3.1 Non-surgical therapy 47 3M.3.1.1 Follow-up 47 3M.3.1.2 Continuous antibiotic prophylaxis 47 3M.3.2 Surgical treatment 47 3M.3.2.1 Subureteric injection of bulking materials 47 3M.3.2.2 Open surgical techniques 48 3M.3.2.3 Laparoscopy 48 3M.3.3 Recommendations for the management of vesicoureteric reflux in childhood 49 3N URINARY STONE DISEASE 51 3N.1 Epidemiology, aetiology and pathophysiology 51 3N.2 Classification systems 51 3N.2.1 Calcium stones 51 3N.2.2 Uric acid stones 52 3N.2.3 Cystine stones 53 3N.2.4 Infection stones (struvite stones) 53 3N.3 Diagnostic evaluation 53 3N.3.1 Imaging 55 3N.3.2 Metabolic evaluation 55 3N.4 Disease management 55 3N.4.1 Extracorporeal shock wave lithotripsy 55 3N.4.2 Percutaneous nephrolithotomy 56 3N.4.3 Ureterorenoscopy 57 4 PAEDIATRIC UROLOGY - LIMITED UPDATE MARCH 2015 3N.4.4 Open or laparoscopic stone surgery 57 3N.5 Conclusions and recommendations 58 3O OBSTRUCTIVE PATHOLOGY OF RENAL DUPLICATION: URETEROCELE AND ECTOPIC URETER 59 3O.1 Epidemiology, aetiology and pathophysiology 59 3O.1.1 Ureterocele 59 3O.1.2 Ectopic ureter 59 3O.2 Classification systems 59 3O.2.1 Ureterocele 59 3O.2.1.1 Ectopic (extravesical) ureterocele 59 3O.2.1.2 Orthotopic (intravesical) ureterocele 59 3O.2.2 Ectopic ureter 59 3O.3 Diagnostic evaluation 60 3O.3.1 Ureterocele 60 3O.3.2 Ectopic ureter 60 3O.4 Disease management 60 3O.4.1 Ureterocele 60 3O.4.1.1 Early treatment 61 3O.4.1.2 Re-evaluation 61 3O.4.2 Ectopic ureter 61 3O.5 Conclusions and recommendations for obstructive pathology of renal duplication: ureterocele and ectopic ureter 62 3P DISORDERS OF SEX DEVELOPMENT 63 3P.1 Epidemiology, aetiology and pathophysiology 63 3P.1.1 Micropenis 63 3P.2 Diagnostic evaluation 63 3P.2.1 The neonatal emergency 63 3P.2.1.1 Family history and clinical examination 64 3P.2.1.2 Choice of laboratory investigations 64 3P.2.2 Gender assignment 65 3P.2.3 Role of the paediatric urologist 65 3P.2.3.1 Clinical examination 65 3P.2.3.2 Investigations 65 3P.3 Disease management 66 3P.3.1 Feminising surgery 66 3P.3.2 Masculinising surgery 66 3P.4 Guidelines for the treatment of disorders of sex development 67 3Q POSTERIOR URETHRAL VALVES 67 3Q.1 Epidemiology, aetiology and pathophysiology 67 3Q.2 Classification systems 67 3Q.2.1 Urethral valve 67 3Q.3 Diagnostic evaluation 68 3Q.4 Disease management 68 3Q.4.1 Antenatal treatment 68 3Q.4.2 Postnatal treatment 68 3Q.5 Follow-up 69 3Q.6 Summary 70 3Q.6.1 Conclusions and recommendations posterior urethral valves 71 3R PAEDIATRIC UROLOGICAL TRAUMA 71 3R.1 Paediatric renal trauma 71 3R.1.1 Epidemiology, aetiology and pathophysiology 71 3R.1.2 Classification systems 72 3R.1.3 Diagnostic evaluation 72 3R.1.3.1 Haematuria 72 3R.1.3.2 Blood pressure 72 3R.1.3.3 Choice of imaging method 72 3R.1.4 Disease management 72 3R.1.5 Recommendations for the diagnosis and treatment of paediatric renal trauma 73 3R.2 Paediatric ureteral trauma 73 3R.2.1 Diagnostic evaluation 73 PAEDIATRIC UROLOGY - LIMITED UPDATE MARCH 2015 5 3R.2.2 Disease management 73 3R.2.3 Recommendations for the diagnosis and treatment of paediatric ureteral trauma 74 3R.3 Paediatric bladder injuries 74 3R.3.1 Diagnostic evaluation 74 3R.3.2 Disease management 74 3R.3.2.1 Intraperitoneal injuries 74 3R.3.2.2 Extraperitoneal injuries 74 3R.3.3 Recommendations for the diagnosis and treatment of paediatric bladder injuries 75 3R.4 Paediatric urethral injuries 75 3R.4.1 Diagnostic evaluation 75 3R.4.2 Disease management 75 3R.4.3 Guidelines for the diagnosis and treatment of paediatric trauma 76 3S POST-OPERATIVE FLUID MANAGEMENT 76 3S.1 Epidemiology, aetiology and pathophysiology 76 3S.2 Disease management 76 3S.2.1 Pre-operative fasting 76 3S.2.2 Maintenance therapy and intra-operative fluid therapy 76 3S.2.3 Post-operative fluid management 78 3S.2.4 Post-operative fasting 78 3S.3 Summary conclusions and recommendations 78 3T POST-OPERATIVE PAIN MANAGEMENT IN CHILDREN: GENERAL INFORMATION 79 3T.1 Epidemiology, aetiology and pathophysiology 79 3T.2 Diagnostic evaluation 79 3T.3 Disease management 79 3T.3.1 Drugs and route of administration 79 3T.3.2 Circumcision 82 3T.3.3 Penile, inguinal and scrotal surgery 82 3T.3.4 Bladder and kidney surgery 82 3T.4 Conclusions and recommendations 83 4.
Load more

Recommended publications
  • Chapter 99 – Urological Disorders Episode Overview Urinary Tract Infections in Adults 1
    Crack Cast Show Notes – Urological Disorders – August 2017 www.crackcast.org Chapter 99 – Urological Disorders Episode Overview Urinary Tract Infections in Adults 1. Differentiate between the three major causes of dysuria in women? (ddx of dysuria) 2. List 3 common UTI pathogens, and list 3 additional pathogens in complicated UTIs 3. Define uncomplicated UTI and antibiotic options 4. Define complicated UTI and antibiotic options 5. List two antibiotic options for uncomplicated and complicated pyelonephritis. 6. How is pyelonephritis managed in pregnancy? What are safe antibiotic options for bacteriuria in pregnancy? Prostatitis 1. Describe the diagnosis and management of prostatitis Renal Calculi 1. Name the areas of narrowing in the ureter 2. Name 6 risk factors for urolithiasis 3. List 8 alternative diagnoses (other than renal colic) for pain associated with urolithiasis 4. What are indications for hospitalization of patients with urolithiasis Bladder (Vesical) Calculi 1. Describe this condition and its management Acute Scrotal Pain 1. List causes of acute scrotal swelling by age groups (infant, child, adolescent, adult) 2. Describe the physiology, diagnosis and management of testicular torsion 3. Describe the treatment for sexually vs. non-sexually acquired epididymitis Acute Urinary Retention 1. Describe the physiology of urination 2. List 10 causes of acute urinary retention in adults 3. List 6 causes of urinary retention in women Hematuria 1. List causes of red-coloured urine without hematuria 2. List risk factors for urinary tract malignancy Wisecracks: 1. When is a urine culture indicated (box 89.1) 2. What is a CAUTI and how is it managed? 3. What are two medication classes of drugs for prostatic enlargement? 4.
    [Show full text]
  • “If We Could Change Ourselves, the Tendencies
    10/10/17 GENDERED INEQUALITY: DECONSTRUCTING BARRIERS TO ENABLE SENSITIVE SYSTEMIC “IF WE COULD CHANGE OURSELVES, PRACTICE WITH DIVERSE PEOPLE AND THE TENDENCIES IN THE WORLD RELATIONSHIPS WOULD ALSO CHANGE.” ANNE PROUTY - MAHATMA GANDHI OCTOBER 2017 AUSTRALIAN ASSOCIATION FOR FAMILY THERAPY ANNUAL CONFERENCE ADELAIDE, AUSTRALIA GLOBAL “GENDER” (Binary) Gender Inequities DEADLY CUTTING EDGE * MISERABLE TO PROMOTE SOCIAL JUSTICE * REAL ADVOCATE FOR CLIENTS SEX AND GENDER 2007 “YogyAkArtA Principles”: 28 Principles oF the THE WORLD HEALTH ORGANISATION HAS RECOGNISED ApplicAtion oF International HumAn Rights LAw in SEX AND GENDER GLOBALLY AS CORE SOCIAL RelAtion to SexuaL Orientation DETERMINANTS OF PHYSICAL AND MENTAL HEALTH and Gender Identity 64 AND WELL-BEING 44 • LGBTI are 11% of Australians as of 20146 • www.YogyAkArtAprinciples.org • GENDER Keynote/YogyAkArtA principles_en.pdF • 1.7% oF AustrAliAns Are estimated to be Intersex (AustraliAn HumAn Rights Commission) • 2% oF people globAlly estimAted to be non-binAry gender • 34% oF LGBTI AustrAliAns hide their identity when accessing services 1 10/10/17 ApproAches to IDENTITY SociAl Justice MultiPLe CulturaL Communities • WHO DEFINES WHOM? Human Diversity within Communities/Contexts • EACH PERSON’S EXPERIENCE? Human Diversity Across LifesPans • BY INTERACTING WITH EACH OTHER? • INTERACTING BY PROXY AND VIA COMMUNITIES? INTERSECTIONALITY INTERSECTIONALITY - IDENTITIES INTERSECTIONALITY - IDENTITIES SEX &/OR GENDER ID ETHNIC ID SEX &/OR GENDER ID ETHNIC ID SEXUAL ORIENTATION SPIRITUAL
    [Show full text]
  • Guidelines on Paediatric Urology S
    Guidelines on Paediatric Urology S. Tekgül (Chair), H.S. Dogan, E. Erdem (Guidelines Associate), P. Hoebeke, R. Ko˘cvara, J.M. Nijman (Vice-chair), C. Radmayr, M.S. Silay (Guidelines Associate), R. Stein, S. Undre (Guidelines Associate) European Society for Paediatric Urology © European Association of Urology 2015 TABLE OF CONTENTS PAGE 1. INTRODUCTION 7 1.1 Aim 7 1.2 Publication history 7 2. METHODS 8 3. THE GUIDELINE 8 3A PHIMOSIS 8 3A.1 Epidemiology, aetiology and pathophysiology 8 3A.2 Classification systems 8 3A.3 Diagnostic evaluation 8 3A.4 Disease management 8 3A.5 Follow-up 9 3A.6 Conclusions and recommendations on phimosis 9 3B CRYPTORCHIDISM 9 3B.1 Epidemiology, aetiology and pathophysiology 9 3B.2 Classification systems 9 3B.3 Diagnostic evaluation 10 3B.4 Disease management 10 3B.4.1 Medical therapy 10 3B.4.2 Surgery 10 3B.5 Follow-up 11 3B.6 Recommendations for cryptorchidism 11 3C HYDROCELE 12 3C.1 Epidemiology, aetiology and pathophysiology 12 3C.2 Diagnostic evaluation 12 3C.3 Disease management 12 3C.4 Recommendations for the management of hydrocele 12 3D ACUTE SCROTUM IN CHILDREN 13 3D.1 Epidemiology, aetiology and pathophysiology 13 3D.2 Diagnostic evaluation 13 3D.3 Disease management 14 3D.3.1 Epididymitis 14 3D.3.2 Testicular torsion 14 3D.3.3 Surgical treatment 14 3D.4 Follow-up 14 3D.4.1 Fertility 14 3D.4.2 Subfertility 14 3D.4.3 Androgen levels 15 3D.4.4 Testicular cancer 15 3D.5 Recommendations for the treatment of acute scrotum in children 15 3E HYPOSPADIAS 15 3E.1 Epidemiology, aetiology and pathophysiology
    [Show full text]
  • Testicular Prosthesis in Paediatric Urology: Current Concepts and Available Alternatives
    Review Article Testicular Prosthesis in Paediatric Urology: Current Concepts and Available Alternatives Nitin Sharma, M. Bajpai and Shasanka Shekhar Panda Department of Paediatric Surgery, All India Institute of Medical Sciences, New Delhi-110029, India Abstract: Prosthesis is an artificial material used as a replacement for its natural counterpart. Use of testicular prosthesis in pediatric urology is limited and indications are well defined. In this review we tried to find out and summarize the current indications and available options in pediatric urology for these prosthesis. Keywords: Testicular prosthesis, Orchidometer, Anorchia Prosthesis is an artificial material used as a replacement for c). Torsion its natural counterpart. Use of testicular prosthesis in pediatric d). Dysplasia urology is limited and indications are well defined. In this e). Dysgenesis review we tried to find out and summarize the current f). Intersex disorders requiring male genitoplasty indications and available options in pediatric urology for these B). Assessment of the size of prosthesis required: prosthesis. An extensive PubMed, Medline and Google scholar search was done to see the available literature and This entirely depends upon the age at placement of the current practice. For the purpose of simplicity the subsequent prosthesis and the scrotal development. The assessment of discussion is under following heads: the volume of testis is done using an instrument called as Orchidometer/ Orchiometer. The orchidometer was introduced Indications for the first time by Swiss pediatric endocrinologist Prof. Assessment of size required Andrea Prader1 of university of Zurich in 1966. It consists of Timing a string of twelve numbered wooden or plastic beads (some Procedure time referred as Prader's balls, medical worry beads or Complications endocrine rosary) of increasing size from one to twenty-five Evolution and currently available options milliliters (Fig 1).
    [Show full text]
  • A Clinical Case of Fournier's Gangrene: Imaging Ultrasound
    J Ultrasound (2014) 17:303–306 DOI 10.1007/s40477-014-0106-5 CASE REPORT A clinical case of Fournier’s gangrene: imaging ultrasound Marco Di Serafino • Chiara Gullotto • Chiara Gregorini • Claudia Nocentini Received: 24 February 2014 / Accepted: 17 March 2014 / Published online: 1 July 2014 Ó Societa` Italiana di Ultrasonologia in Medicina e Biologia (SIUMB) 2014 Abstract Fournier’s gangrene is a rapidly progressing Introduction necrotizing fasciitis involving the perineal, perianal, or genital regions and constitutes a true surgical emergency Fournier’s gangrene is an acute, rapidly progressive, and with a potentially high mortality rate. Although the diagnosis potentially fatal, infective necrotizing fasciitis affecting the of Fournier’s gangrene is often made clinically, emergency external genitalia, perineal or perianal regions, which ultrasonography and computed tomography lead to an early commonly affects men, but can also occur in women and diagnosis with accurate assessment of disease extent. The children [1]. Although originally thought to be an idio- Authors report their experience in ultrasound diagnosis of pathic process, Fournier’s gangrene has been shown to one case of Fournier’s gangrene of testis illustrating the main have a predilection for patients with state diabetes mellitus sonographic signs and imaging diagnostic protocol. as well as long-term alcohol misuse. However, it can also affect patients with non-obvious immune compromise. Keywords Fournier’s gangrene Á Sonography Comorbid systemic disorders are being identified more and more in patients with Fournier’s gangrene. Diabetes mel- Riassunto La gangrena di Fournier e` una fascite necro- litus is reported to be present in 20–70 % of patients with tizzante a rapida progressione che coinvolge il perineo, le Fournier’s Gangrene [2] and chronic alcoholism in regioni perianale e genitali e costituisce una vera emer- 25–50 % patients [3].
    [Show full text]
  • Urologic Disorders
    Urologic Disorders Abdulaziz Althunayan Consultant Urologist Assistant professor of Surgery Urologic Disorders Urinary tract infections Urolithiasis Benign Prostatic Hyperplasia and voiding dysfunction Urinary tract infections Urethritis Acute Pyelonephritis Epididymitis/orchitis Chronic Pyelonephritis Prostatitis Renal Abscess cystitis URETHRITIS S&S – urethral discharge – burning on urination – Asymptomatic Gonococcal vs. Nongonococcal DX: – incubation period(3-10 days vs. 1-5 wks) – Urethral swab – Serum: Chlamydia-specific ribosomal RNA URETHRITIS Epididymitis Acute : pain, swelling, of the epididymis <6wk chronic :long-standing pain in the epididymis and testicle, usu. no swelling. DX – Epididymitis vs. Torsion – U/S – Testicular scan – Younger : N. gonorrhoeae or C. trachomatis – Older : E. coli Epididymitis Prostatitis Syndrome that presents with inflammation± infection of the prostate gland including: – Dysuria, frequency – dysfunctional voiding – Perineal pain – Painful ejaculation Prostatitis Prostatitis Acute Bacterial Prostatitis : – Rare – Acute pain – Storage and voiding urinary symptoms – Fever, chills, malaise, N/V – Perineal and suprapubic pain – Tender swollen hot prostate. – Rx : Abx and urinary drainage cystitis S&S: – dysuria, frequency, urgency, voiding of small urine volumes, – Suprapubic /lower abdominal pain – ± Hematuria – DX: dip-stick urinalysis Urine culture Pyelonephritis Inflammation of the kidney and renal pelvis S&S : – Chills – Fever – Costovertebral angle tenderness (flank Pain) – GI:abdo pain, N/V, and
    [Show full text]
  • Paraffin Granuloma Associated with Buried Glans Penis-Induced Sexual and Voiding Dysfunction
    pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health 2017 August 35(2): 129-132 https://doi.org/10.5534/wjmh.2017.35.2.129 Case Report Paraffin Granuloma Associated with Buried Glans Penis-Induced Sexual and Voiding Dysfunction Wonhee Chon1, Ja Yun Koo1, Min Jung Park3, Kyung-Un Choi2, Hyun Jun Park1,3, Nam Cheol Park1,3 Departments of 1Urology and 2Pathology, Pusan National University School of Medicine, 3The Korea Institute for Public Sperm Bank, Busan, Korea A paraffinoma is a type of inflammatory lipogranuloma that develops after the injection of an artificial mineral oil, such as paraffin or silicon, into the foreskin or the subcutaneous tissue of the penis for the purpose of penis enlargement, cosmetics, or prosthesis. The authors experienced a case of macro-paraffinoma associated with sexual dysfunction, voiding dysfunction, and pain caused by a buried glans penis after a paraffin injection for penis enlargement that had been performed 35 years previously. Herein, this case is presented with a literature review. Key Words: Granuloma; Oils; Paraffin; Penis A paraffinoma is a type of inflammatory lipogranuloma because of tuberculous epididymitis [1,3]. that develops after the injection of an artificial mineral oil, However, various types of adverse effects were sub- such as paraffin or silicon, into the foreskin or the subcuta- sequently reported by several investigators, and such pro- neous tissue of the penis for the purpose of penis enlarge- cedures gradually became less common [3-6]. Paraffin in- ment, cosmetics, or prosthesis [1]. In particular, as this pro- jections display outcomes consistent with the purpose of cedure is performed illegally by non-medical personnel in the procedure in early stages, but over time, the foreign an unsterilized environment or with non-medical agents, matter migrates from the primary injection site to nearby cases of adverse effects, such as infection, skin necrosis, tissues or even along the inguinal lymphatic vessel.
    [Show full text]
  • Non-Certified Epididymitis DST.Pdf
    Clinical Prevention Services Provincial STI Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 Tel : 604.707.5600 Fax: 604.707.5604 www.bccdc.ca BCCDC Non-certified Practice Decision Support Tool Epididymitis EPIDIDYMITIS Testicular torsion is a surgical emergency and requires immediate consultation. It can mimic epididymitis and must be considered in all people presenting with sudden onset, severe testicular pain. Males less than 20 years are more likely to be diagnosed with testicular torsion, but it can occur at any age. Viability of the testis can be compromised as soon as 6-12 hours after the onset of sudden and severe testicular pain. SCOPE RNs must consult with or refer all suspect cases of epididymitis to a physician (MD) or nurse practitioner (NP) for clinical evaluation and a client-specific order for empiric treatment. ETIOLOGY Epididymitis is inflammation of the epididymis, with bacterial and non-bacterial causes: Bacterial: Chlamydia trachomatis (CT) Neisseria gonorrhoeae (GC) coliforms (e.g., E.coli) Non-bacterial: urologic conditions trauma (e.g., surgery) autoimmune conditions, mumps and cancer (not as common) EPIDEMIOLOGY Risk Factors STI-related: condomless insertive anal sex recent CT/GC infection or UTI BCCDC Clinical Prevention Services Reproductive Health Decision Support Tool – Non-certified Practice 1 Epididymitis 2020 BCCDC Non-certified Practice Decision Support Tool Epididymitis Other considerations: recent urinary tract instrumentation or surgery obstructive anatomic abnormalities (e.g., benign prostatic
    [Show full text]
  • Evaluation and Treatment of Acute Urinary Retention
    The Journal of Emergency Medicine, Vol. 35, No. 2, pp. 193–198, 2008 Copyright © 2008 Elsevier Inc. Printed in the USA. All rights reserved 0736-4679/08 $–see front matter doi:10.1016/j.jemermed.2007.06.039 Technical Tips EVALUATION AND TREATMENT OF ACUTE URINARY RETENTION Gary M. Vilke, MD,* Jacob W. Ufberg, MD,† Richard A. Harrigan, MD,† and Theodore C. Chan, MD* *Department of Emergency Medicine, University of California, San Diego Medical Center, San Diego, California and †Department of Emergency Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania Reprint Address: Gary M. Vilke, MD, Department of Emergency Medicine, UC San Diego Medical Center, 200 West Arbor Drive Mailcode #8676, San Diego, CA 92103 e Abstract—Acute urinary retention is a common presen- ETIOLOGY OF ACUTE URINARY RETENTION tation to the Emergency Department and is often simply treated with placement of a Foley catheter. However, var- Acute obstruction of urinary outflow is most often the ious cases will arise when this will not remedy the retention result of physical blockages or by urinary retention and more aggressive measures will be needed, particularly caused by medications. The most common cause of acute if emergent urological consultation is not available. This urinary obstruction continues to be benign prostatic hy- article will review the causes of urinary obstruction and pertrophy, with other obstructive causes listed in Table 1 systematically review emergent techniques and procedures (4). Common medications that can result in acute
    [Show full text]
  • Guidelines of Hypertension – 2020 Barroso Et Al
    Brazilian Guidelines of Hypertension – 2020 Barroso et al. Guidelines Brazilian Guidelines of Hypertension – 2020 Development: Department of Hypertension of the Brazilian Society of Cardiology (DHA-SBC), Brazilian Society of Hypertension (SBH), Brazilian Society of Nephrology (SBN) Norms and Guidelines Council (2020-2021): Brivaldo Markman Filho, Antonio Carlos Sobral Sousa, Aurora Felice Castro Issa, Bruno Ramos Nascimento, Harry Correa Filho, Marcelo Luiz Campos Vieira Norms and Guidelines Coordinator (2020-2021): Brivaldo Markman Filho General Coordinator: Weimar Kunz Sebba Barroso Coordination Work Group: Weimar Kunz Sebba Barroso, Cibele Saad Rodrigues, Luiz Aparecido Bortolotto, Marco Antônio Mota-Gomes Guideline Authors: Weimar Kunz Sebba Barroso,1,2 Cibele Isaac Saad Rodrigues,3 Luiz Aparecido Bortolotto,4 Marco Antônio Mota-Gomes,5 Andréa Araujo Brandão,6 Audes Diógenes de Magalhães Feitosa,7,8 Carlos Alberto Machado,9 Carlos Eduardo Poli-de-Figueiredo,10 Celso Amodeo,11 Décio Mion Júnior,12 Eduardo Costa Duarte Barbosa,13 Fernando Nobre,14,15 Isabel Cristina Britto Guimarães,16 José Fernando Vilela- Martin,17 Juan Carlos Yugar-Toledo,17 Maria Eliane Campos Magalhães,18 Mário Fritsch Toros Neves,6 Paulo César Brandão Veiga Jardim,2,19 Roberto Dischinger Miranda,11 Rui Manuel dos Santos Póvoa,11 Sandra C. Fuchs,20 Alexandre Alessi,21 Alexandre Jorge Gomes de Lucena,22 Alvaro Avezum,23 Ana Luiza Lima Sousa,1,2 Andrea Pio-Abreu,24 Andrei Carvalho Sposito,25 Angela Maria Geraldo Pierin,24 Annelise Machado Gomes de Paiva,5 Antonio
    [Show full text]
  • Phimosis Table of Contents
    Information for Patients English Phimosis Table of contents What is phimosis? ................................................................................................. 3 How common is phimosis? ............................................................................. 3 What causes phimosis? ..................................................................................... 3 Symptoms and Diagnosis ................................................................................. 3 Treatment ................................................................................................................... 4 Topical steroid .......................................................................................................... 4 Circumcision .............................................................................................................. 4 How is circumcision performed? .................................................................. 4 Recovery ...................................................................................................................... 5 Paraphimosis ........................................................................................................... 5 Emergency treatment ....................................................................................... 5 Living with phimosis ........................................................................................... 5 Glossary ................................................................................... 6 This information
    [Show full text]
  • IPEG's 25Th Annual Congress Forendosurgery in Children
    IPEG’s 25th Annual Congress for Endosurgery in Children Held in conjunction with JSPS, AAPS, and WOFAPS May 24-28, 2016 Fukuoka, Japan HELD AT THE HILTON FUKUOKA SEA HAWK FINAL PROGRAM 2016 LY 3m ON m s ® s e d’ a rl le o r W YOU ASKED… JustRight Surgical delivered W r o e r l ld p ’s ta O s NL mm Y classic 5 IPEG…. Now it’s your turn RIGHT Come try these instruments in the Hands-On Lab: SIZE. High Fidelity Neonatal Course RIGHT for the Advanced Learner Tuesday May 24, 2016 FIT. 2:00pm - 6:00pm RIGHT 357 S. McCaslin, #120 | Louisville, CO 80027 CHOICE. 720-287-7130 | 866-683-1743 | www.justrightsurgical.com th IPEG’s 25 Annual Congress Welcome Message for Endosurgery in Children Dear Colleagues, May 24-28, 2016 Fukuoka, Japan On behalf of our IPEG family, I have the privilege to welcome you all to the 25th Congress of the THE HILTON FUKUOKA SEA HAWK International Pediatric Endosurgery Group (IPEG) in 810-8650, Fukuoka-shi, 2-2-3 Jigyohama, Fukuoka, Japan in May of 2016. Chuo-ku, Japan T: +81-92-844 8111 F: +81-92-844 7887 This will be a special Congress for IPEG. We have paired up with the Pacific Association of Pediatric Surgeons International Pediatric Endosurgery Group (IPEG) and the Japanese Society of Pediatric Surgeons to hold 11300 W. Olympic Blvd, Suite 600 a combined meeting that will add to our always-exciting Los Angeles, CA 90064 IPEG sessions a fantastic opportunity to interact and T: +1 310.437.0553 F: +1 310.437.0585 learn from the members of those two surgical societies.
    [Show full text]